relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text History 11 Sponsors 2

No summary has been published for this bill.

Chamber: House
Introduced: Jan 3, 2023
Last action: Nov 16, 2023 — Committee Report: Inexpedient to Legislate HB172 11/08/2023 (Vote 19-0; CC)
Sponsor: Jess Edwards R
Session: 2023
Momentum: 5 · Stalled